Bioprocessing Application Notes & Case Studies

  1. Custom Formulation Solution Including An Animal-Origin Element 12/18/2023

    Explore the customized, multi-component solution designed to meet quality and packaging specifications, while including an animal-origin element, as well as a non-compendial component.

  2. Searching For A CDMO To Support Affordable Conjugate Vaccines 12/14/2023

    Learn how a CDMO that prioritizes custom, flexible partnership over a transactional relationship is crucial for long-term programs and for tailoring services to meet the needs of small-volume clients.

  3. A Partnership To Deliver Excellence In Antibody Discovery And Production 12/6/2023

    Explore the partnership that assisted FairJourney Biologics in methodically handling 30 to 40 different production projects concurrently.

  4. Safer And Faster Conjugation And Purification Of ADCs At 1-20 L Scale 12/5/2023

    Explore data demonstrating the successful engineering of a single-use tangential flow filtration system designed to meet the specific requirements of ADC processes.

  5. Achieve Manufacturing Scale For Your Viral Vector Production 12/4/2023

    Elevate your viral vector production to commercial scale by choosing the optimal production system paired with the right single-use bioreactor combination.

  6. Production And Purification Of AAV At The 50 L Scale 12/4/2023

    Explore data demonstrating the performance of a scalable system for AAV manufacturing that enables gene therapy researchers to utilize a single system throughout the entire development process.

  7. Optimizing End-To-End Processes To Reduce Costs And Improve Yields 11/30/2023

    Explore the challenges faced by a large CDMO as well as the solutions that were provided to achieve significant time savings, cost savings, and the removal of a major downstream process limitation.

  8. Reagents For Highly Efficient T Cell Manufacturing 11/29/2023

    See how enhanced T cell expansion as well as the generation of an early-differentiated phenotype can be achieved using a cell culture medium for T cells and cytokines, in a static bioreactor system.

  9. Chromatographic Separation Of Full And Empty AAV8 Capsids 11/29/2023

    Here, we demonstrate a rapid method for the separation of empty and full AAV8 particles by linear gradient elution on CIMmultus® QA monoliths with 80% recovery.

  10. Intensifying A mAb Polishing Platform 11/29/2023

    We demonstrate how a mAb purification batch process can be converted into a stepwise intensified batch process, successfully eliminating intermediate steps and achieving over 13% cost reductions.